We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+12.03%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$1.04T
AUM Growth
+$136B
Cap. Flow
+$33.3B
Cap. Flow %
3.19%
Top 10 Hldgs %
19.7%
Holding
8,129
New
701
Increased
3,666
Reduced
2,249
Closed
619

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Healthcare 9.65%
3 Financials 9.27%
4 Consumer Discretionary 8.86%
5 Industrials 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FEIM icon
6701
Frequency Electronics
FEIM
$856M
$383 ﹤0.01%
35
+27
+338% +$232
IMDX
6702
Insight Molecular Diagnostics
IMDX
$121M
$382 ﹤0.01%
154
PRAX icon
6703
Praxis Precision Medicines
PRAX
$10.3B
$379 ﹤0.01%
17
-81
-83% -$1.46K
SNDA icon
6704
Sonida Senior Living
SNDA
$1.88B
$377 ﹤0.01%
39
+36
+1,200% +$337
CYT
6705
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$377 ﹤0.01%
124
-372
-75% -$1.13K
ELMD icon
6706
Electromed
ELMD
$352M
$371 ﹤0.01%
34
BFI
6707
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$368 ﹤0.01%
428
+8
+2% +$8
GHG
6708
GreenTree Hospitality
GHG
$111M
$361 ﹤0.01%
96
PVLA
6709
Palvella Therapeutics
PVLA
$2.26B
$358 ﹤0.01%
25
-1,379
-98% -$25.3K
SNAXW
6710
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
0
NKTR icon
6711
Nektar Therapeutics
NKTR
$2.57B
$357 ﹤0.01%
42
-2,407
-98% -$18.2K
USAU icon
6712
US Gold Corp
USAU
$249M
$357 ﹤0.01%
84
-1,000
-92% -$3.43K
GIFI
6713
DELISTED
Gulf Island Fabrication
GIFI
$351 ﹤0.01%
81
+65
+406% +$263
KA
6714
DELISTED
Kineta, Inc. Common Stock
KA
$351 ﹤0.01%
99
-83
-46% -$312
VHC icon
6715
VirnetX Holding Corp
VHC
$64.8M
$350 ﹤0.01%
50
+2
+4% +$13
QMOM icon
6716
Alpha Architect US Quantitative Momentum ETF
QMOM
$446M
$349 ﹤0.01%
+7
New +$317
SSKN
6717
DELISTED
Strata Skin Sciences
SSKN
$349 ﹤0.01%
63
+60
+2,000% +$312
GAIA icon
6718
Gaia
GAIA
$33.3M
$348 ﹤0.01%
129
+115
+821% +$309
LONA
6719
LeonaBio Inc
LONA
$73.9M
$347 ﹤0.01%
14
-85
-86% -$1.51K
SPRO icon
6720
Spero Therapeutics
SPRO
$71.8M
$347 ﹤0.01%
236
PPSI
6721
Pioneer Power Solutions
PPSI
$33.5M
$346 ﹤0.01%
51
+47
+1,175% +$279
APVO icon
6722
Aptevo Therapeutics
APVO
$5.16M
0
INTS icon
6723
Intensity Therapeutics
INTS
$10.8M
$343 ﹤0.01%
+2
New +$211
TALKW
6724
DELISTED
Talkspace Inc Warrant
TALKW
0
YARW
6725
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$341 ﹤0.01%
3

Similar funds

JP Morgan Chase's Q4 2023 Portfolio in Review

As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.

  • JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
  • JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
  • JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
  • JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
  • JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
  • JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.

Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.